He, Yong
Hwang, Seonghwan
Ahmed, Yeni Ait
Feng, Dechun
Li, Na
Ribeiro, Marcelle
Lafdil, Fouad
Kisseleva, Tatiana
Szabo, Gyongyi
Gao, Bin
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (intramural program)
Article History
Received: 9 September 2020
Accepted: 15 October 2020
First Online: 17 November 2020
Competing interests
: G.S. consults for Allergan, Alnylam, Arrow, Durcect Corporation, Generon, Glympse Bio, Terra Firma, Quest Diagnostics, Pandion Therapeutics, Surrozen, and Zomagen. She has received grants from Gilead, Genfit, Intercept, Novartis, SignaBlok, and Shire. She holds intellectual property rights with Up to Date. The other coauthors declare no competing interests.